Evidence map›Paper›PMID 24973092›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2014

Intracellular generation of ROS by 3,5-dimethylaminophenol: persistence, cellular response, and impact of molecular toxicity.

Ming-Wei Chao, Pinar Erkekoglu, Chia-Yi Tseng, Wenjie Ye, Laura J Trudel, Paul L Skipper, Steven R Tannenbaum, Gerald N Wogan

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Ming-Wei ChaoDepartment of Bioscience Technology, Chung Yuan Christian University, Chungli City, Taoyuan 32023, Taiwan Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 chao@cycu.edu.tw.
Pinar ErkekogluDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Department of Toxicology, Faculty of Pharmacy, Hacettepe University, Sihhiye-Ankara, Turkey.
Chia-Yi TsengDepartment of Biomedical Engineering, Chung Yuan Christian University, Chungli City, Taoyuan 32023, Taiwan.
Wenjie YeDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Laura J TrudelDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Paul L SkipperDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Steven R TannenbaumDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Gerald N WoganDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Massachusetts Institute of Technology · USChung Yuan Christian University · TWHacettepe University · TR

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEVINE, STUART S · 1985 to 2020
$25.6M
Validation and Application of Risk, Biomarkers in Human StudiesP01ES006052 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI GROOPMAN, JOHN D · 1993 to 2012
$22.6M
NIEHS NIH HHS ES02109NIEHS NIH HHS P01 ES006052NIEHS NIH HHS P30 ES002109
6 · The paper itself

Abstract

Epidemiological studies have demonstrated extensive human exposure to the monocyclic aromatic amines, particularly to 3,5-dimethylaniline, and found an association between exposure to these compounds and risk for bladder cancer. Little is known about molecular mechanisms that might lead to the observed risk. We previously suggested that the hydroxylated 3,5-dimethylaniline metabolite, 3,5-dimethylaminophenol (3,5-DMAP), played a central role in effecting genetic change through the generation of reactive oxygen species (ROS) in a redox cycle with 3,5-dimethylquinoneimine. Experiments here characterize ROS generation by 3,5-DMAP exposure in nucleotide repair-proficient and -deficient Chinese hamster ovary cells as a function of time. Besides, various cellular responses discussed herein indicate that ROS production is the principal cause of cytotoxicity. Fluorescence microscopy of cells exposed to 3,5-DMAP confirmed that ROS production occurs in the nuclear compartment, as suggested by a previous study demonstrating covalent linkage between 3,5-DMAP and histones. 3,5-DMAP was also compared with 3,5-dimethylhydroquinone to determine whether substitution of one of the phenolic hydroxyl groups by an amino group had a significant effect on some of the investigated parameters. The comparatively much longer duration of observable ROS produced by 3,5-DMAP (7 vs. 1 day) provides further evidence that 3,5-DMAP becomes embedded in the cellular matrix in a form capable of continued redox cycling. 3,5-DMAP also induced dose-dependent increase of H2O2 and ·OH, which were determined as the major free radicals contributing to the cytotoxicity and apoptosis mediated via caspase-3 activation. Overall, this study provides insight into the progression of alkylaniline-induced toxicity.

Indexed as

AminophenolsAnimalsApoptosisCell NucleusCell SurvivalCHO CellsCricetinaeCricetulusDose-Response Relationship, DrugHistonesMicroscopy, FluorescenceOxidative StressReactive Oxygen Species3,5-dimethylaminophenolAminophenolsHistonesReactive Oxygen Speciesapoptosisdimethylaminophenolhydroquinonequinone iminereactive oxygen species

Identifiers

PMID24973092
PMCPMC4271125
OpenAlexW2136555199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.